Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression
出版年份 2019 全文链接
标题
Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression
作者
关键词
-
出版物
Cancers
Volume 11, Issue 5, Pages 614
出版商
MDPI AG
发表日期
2019-05-07
DOI
10.3390/cancers11050614
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nrf2 in cancers: A double‐edged sword
- (2019) Shijia Wu et al. Cancer Medicine
- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatment
- (2018) Christophe Glorieux et al. Cancer Cell International
- New therapeutic strategies to treat human cancers expressing mutant p53 proteins
- (2018) Giovanni Blandino et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
- (2018) Yukai Xiang et al. Oxidative Medicine and Cellular Longevity
- Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
- (2018) Adam J. Wolpaw et al. TRENDS IN CELL BIOLOGY
- Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
- (2018) Kamil Lisek et al. Oncotarget
- Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
- (2018) Ramona Schulz-Heddergott et al. Cancers
- mTOR Pathways in Cancer and Autophagy
- (2018) Mathieu Paquette et al. Cancers
- Life, death and autophagy
- (2018) Johnna Doherty et al. NATURE CELL BIOLOGY
- p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
- (2018) Sung-Hwan Moon et al. CELL
- Mutant p53 as a guardian of the cancer cell
- (2018) Fiamma Mantovani et al. CELL DEATH AND DIFFERENTIATION
- The role of cellular reactive oxygen species in cancer chemotherapy
- (2018) Haotian Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
- (2018) Chiranjeev Sharma et al. MOLECULES
- p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression
- (2018) Ivano Amelio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Essential Roles of E3 Ubiquitin Ligases in p53 Regulation
- (2017) Sanam Sane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
- (2017) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Deptor: not only a mTOR inhibitor
- (2017) Valeria Catena et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
- (2017) Marisa Granato et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mechanical cues control mutant p53 stability through a mevalonate–RhoA axis
- (2017) Eleonora Ingallina et al. NATURE CELL BIOLOGY
- Regulation of heat shock transcription factors and their roles in physiology and disease
- (2017) Rocio Gomez-Pastor et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
- (2017) Tianchi Yu et al. YONSEI MEDICAL JOURNAL
- Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
- (2017) T Avril et al. Oncogenesis
- Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice
- (2017) L. Masuelli et al. OncoImmunology
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis
- (2016) Marco Cordani et al. CANCER LETTERS
- Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth
- (2016) M Aggarwal et al. CELL DEATH AND DIFFERENTIATION
- Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy
- (2016) Evguenia M Alexandrova et al. CELL DEATH AND DIFFERENTIATION
- Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt’s lymphoma
- (2016) Marisa Granato et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Stress management by autophagy: Implications for chemoresistance
- (2016) Zhao Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Mutant p53 and mTOR/PKM2 regulation in cancer cells
- (2016) Ilaria Dando et al. IUBMB LIFE
- Reactivation of mutant p53 by capsaicin, the major constituent of peppers
- (2016) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity
- (2016) Aymone Gurtner et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition
- (2016) Marco Cordani et al. Molecular Oncology
- Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
- (2016) Dawid Walerych et al. NATURE CELL BIOLOGY
- DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway
- (2016) Alejandro Parrales et al. NATURE CELL BIOLOGY
- Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5
- (2016) Fotini Vogiatzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Dual Roles of NRF2 in Cancer
- (2016) Silvia Menegon et al. TRENDS IN MOLECULAR MEDICINE
- Heat Shock Factor 1 in Protein Homeostasis and Oncogenic Signal Integration
- (2015) T. Home et al. CANCER RESEARCH
- p62 links autophagy and Nrf2 signaling
- (2015) Tao Jiang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Zn(II)-curc targets p53 in thyroid cancer cells
- (2015) ALESSIA GARUFI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer
- (2015) Jun Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- UPR, autophagy, and mitochondria crosstalk underlies the ER stress response
- (2015) Daniela Senft et al. TRENDS IN BIOCHEMICAL SCIENCES
- Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation
- (2015) Evrim Gurpinar et al. TRENDS IN CELL BIOLOGY
- Transcription factors Hsf1 and Nrf2 engage in crosstalk for cytoprotection
- (2015) Sharadha Dayalan Naidu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications
- (2015) S Baldari et al. Cell Death & Disease
- Endoplasmic Reticulum Stress-Activated Cell Reprogramming in Oncogenesis
- (2015) E. Chevet et al. Cancer Discovery
- Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway
- (2015) Takushi Namba et al. Oncotarget
- Mutant p53 – Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival
- (2015) Evguenia M. Alexandrova et al. Frontiers in Endocrinology
- Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer
- (2015) Michael Paul Kim et al. Frontiers in Oncology
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- Ganetespib and HSP90: Translating Preclinical Hypotheses into Clinical Promise
- (2014) D. A. Proia et al. CANCER RESEARCH
- Knockdown of estrogen receptor-α induces autophagy and inhibits antiestrogen-mediated unfolded protein response activation, promoting ROS-induced breast cancer cell death
- (2014) Katherine L. Cook et al. FASEB JOURNAL
- Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (Review)
- (2014) Zuzana Sol�rov� et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents
- (2014) Ponsilp Zeekpudsa et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical implications of high NQO1 expression in breast cancers
- (2014) Yang Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
- (2014) Xi Chen et al. NATURE
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Turmeric Toxicity in A431 Epidermoid Cancer Cells Associates with Autophagy Degradation of Anti-apoptotic and Anti-autophagic p53 Mutant
- (2014) Visa Thongrakard et al. PHYTOTHERAPY RESEARCH
- Illuminating p53 function in cancer with genetically engineered mouse models
- (2014) Patty B. Garcia et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Drugging the HDAC6–HSP90 interplay in malignant cells
- (2014) Oliver H. Krämer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress
- (2014) D Li et al. Cell Death & Disease
- Degradation of mutant p53H175 protein by Zn(II) through autophagy
- (2014) A Garufi et al. Cell Death & Disease
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Chaperone-mediated autophagy degrades mutant p53
- (2013) H. Vakifahmetoglu-Norberg et al. GENES & DEVELOPMENT
- A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
- (2013) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nutrient regulation of the mTOR Complex 1 signaling pathway
- (2013) Sang Gyun Kim et al. MOLECULES AND CELLS
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2
- (2013) Feili Chen et al. PHARMACOGENOMICS
- Nutrient signaling to mTOR and cell growth
- (2013) Jenna L. Jewell et al. TRENDS IN BIOCHEMICAL SCIENCES
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Dietary downregulation of mutant p53 levels via glucose restriction
- (2012) Olga Catalina Rodriguez et al. CELL CYCLE
- Stress-induced self-cannibalism: on the regulation of autophagy by endoplasmic reticulum stress
- (2012) Shane Deegan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Mutant p53R273Hattenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species
- (2012) Eyal Kalo et al. JOURNAL OF CELL SCIENCE
- Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis
- (2012) Chengkai Dai et al. JOURNAL OF CLINICAL INVESTIGATION
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- The unfolded protein response: controlling cell fate decisions under ER stress and beyond
- (2012) Claudio Hetz NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies
- (2012) B Luo et al. ONCOGENE
- Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
- (2012) Milena Wiech et al. PLoS One
- The p53 network: cellular and systemic DNA damage responses in aging and cancer
- (2012) H. Christian Reinhardt et al. TRENDS IN GENETICS
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Proteotoxic stress of cancer: Implication of the heat-shock response in oncogenesis
- (2011) Chengkai Dai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
- (2011) D. Li et al. MOLECULAR CANCER RESEARCH
- Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
- (2011) Jie Xu et al. Nature Chemical Biology
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
- (2011) D. Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- (2011) P. Walter et al. SCIENCE
- Selectively targeting estrogen receptors for cancer treatment
- (2010) Erin K. Shanle et al. ADVANCED DRUG DELIVERY REVIEWS
- Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP
- (2010) Jia Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences
- (2010) D. Menendez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- The role of X-box binding protein-1 in tumorigenicity
- (2009) A.N. Shajahan et al. DRUG NEWS & PERSPECTIVES
- Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
- (2009) Weimin Chen et al. MOLECULAR CELL
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Dual roles of Nrf2 in cancer
- (2008) A LAU et al. PHARMACOLOGICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started